The	O
relationship	O
between	O
hemorheological	B:C0206502
parameters	O
and	O
mortality	O
in	O
critically	O
ill	I:C0010340
patients	O
with	O
and	O
without	O
sepsis	O
.	O

The	O
relationship	O
between	O
hemorheological	O
parameters	B:C0449381
and	O
mortality	O
in	O
critically	O
ill	I:C0010340
patients	O
with	O
and	O
without	O
sepsis	O
.	O

The	O
relationship	O
between	O
hemorheological	O
parameters	O
and	O
mortality	O
in	O
critically	B:C0010340
ill	I:C0010340
patients	O
with	O
and	O
without	O
sepsis	O
.	O

The	O
relationship	O
between	O
hemorheological	O
parameters	O
and	O
mortality	O
in	O
critically	O
ill	I:C0010340
patients	O
with	O
and	O
without	O
sepsis	B:C0243026
.	O

The	O
prognostic	B:C0033325
scoring	O
systems	I:C0282574
for	O
mortality	O
of	O
intensive	O
care	I:C0085559
patients	O
estimate	O
clinical	O
outcome	I:C0243095
using	O
several	O
physiological	O
and	O
biochemical	O
parameters	O
.	O

The	O
prognostic	O
scoring	B:C0282574
systems	I:C0282574
for	O
mortality	O
of	O
intensive	O
care	I:C0085559
patients	O
estimate	O
clinical	O
outcome	I:C0243095
using	O
several	O
physiological	O
and	O
biochemical	O
parameters	O
.	O

The	O
prognostic	O
scoring	O
systems	I:C0282574
for	O
mortality	O
of	O
intensive	B:C0085559
care	I:C0085559
patients	O
estimate	O
clinical	O
outcome	I:C0243095
using	O
several	O
physiological	O
and	O
biochemical	O
parameters	O
.	O

The	O
prognostic	O
scoring	O
systems	I:C0282574
for	O
mortality	O
of	O
intensive	O
care	I:C0085559
patients	O
estimate	O
clinical	B:C0243095
outcome	I:C0243095
using	O
several	O
physiological	O
and	O
biochemical	O
parameters	O
.	O

The	O
prognostic	O
scoring	O
systems	I:C0282574
for	O
mortality	O
of	O
intensive	O
care	I:C0085559
patients	O
estimate	O
clinical	O
outcome	I:C0243095
using	O
several	O
physiological	O
and	O
biochemical	O
parameters	B:C0449381
.	O

In	O
altered	O
hemodynamic	B:C0019010
conditions	O
of	O
critically	O
ill	I:C0010340
patients	O
,	O
hemorheological	O
variables	O
may	O
play	O
a	O
significant	O
role	O
in	O
appropriate	O
tissue	O
perfusion	O
.	O

In	O
altered	O
hemodynamic	O
conditions	O
of	O
critically	B:C0010340
ill	I:C0010340
patients	O
,	O
hemorheological	O
variables	O
may	O
play	O
a	O
significant	O
role	O
in	O
appropriate	O
tissue	O
perfusion	O
.	O

In	O
altered	O
hemodynamic	O
conditions	O
of	O
critically	O
ill	I:C0010340
patients	O
,	O
hemorheological	B:C0206502
variables	O
may	O
play	O
a	O
significant	O
role	O
in	O
appropriate	O
tissue	O
perfusion	O
.	O

In	O
altered	O
hemodynamic	O
conditions	O
of	O
critically	O
ill	I:C0010340
patients	O
,	O
hemorheological	O
variables	B:C1134627
may	O
play	O
a	O
significant	O
role	O
in	O
appropriate	O
tissue	O
perfusion	O
.	O

In	O
altered	O
hemodynamic	O
conditions	O
of	O
critically	O
ill	I:C0010340
patients	O
,	O
hemorheological	O
variables	O
may	O
play	O
a	O
significant	O
role	O
in	O
appropriate	O
tissue	B:C0040300
perfusion	O
.	O

In	O
altered	O
hemodynamic	O
conditions	O
of	O
critically	O
ill	I:C0010340
patients	O
,	O
hemorheological	O
variables	O
may	O
play	O
a	O
significant	O
role	O
in	O
appropriate	O
tissue	O
perfusion	B:C0031001
.	O

We	O
investigated	O
if	O
hemorheological	B:C0206502
parameters	O
are	O
altered	O
in	O
critical	O
status	I:C0184770
and	O
if	O
they	O
could	O
be	O
markers	O
of	O
mortality	O
.	O

We	O
investigated	O
if	O
hemorheological	O
parameters	B:C0449381
are	O
altered	O
in	O
critical	O
status	I:C0184770
and	O
if	O
they	O
could	O
be	O
markers	O
of	O
mortality	O
.	O

We	O
investigated	O
if	O
hemorheological	O
parameters	O
are	O
altered	O
in	O
critical	B:C0184770
status	I:C0184770
and	O
if	O
they	O
could	O
be	O
markers	O
of	O
mortality	O
.	O

We	O
investigated	O
if	O
hemorheological	O
parameters	O
are	O
altered	O
in	O
critical	O
status	I:C0184770
and	O
if	O
they	O
could	O
be	O
markers	B:C0005516
of	O
mortality	O
.	O

112	O
patients	O
(	O
67.8	O
±	O
12	O
years	O
,	O
58	O
males	O
,	O
54	O
females	O
)	O
treated	O
in	O
intensive	B:C0021708
care	I:C0021708
unit	I:C0021708
with	O
different	O
non-surgical	O
diseases	O
were	O
investigated	O
.	O

112	O
patients	O
(	O
67.8	O
±	O
12	O
years	O
,	O
58	O
males	O
,	O
54	O
females	O
)	O
treated	O
in	O
intensive	O
care	I:C0021708
unit	I:C0021708
with	O
different	O
non-surgical	O
diseases	B:C0012634
were	O
investigated	O
.	O

Routine	O
laboratory	B:C0022885
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	O
(	O
hematocrit	O
,	O
plasma	O
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	B:C0206502
variables	O
(	O
hematocrit	O
,	O
plasma	O
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	B:C1134627
(	O
hematocrit	O
,	O
plasma	O
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	O
(	O
hematocrit	B:C0518014
,	O
plasma	O
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	O
(	O
hematocrit	O
,	O
plasma	B:C0032105
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	O
(	O
hematocrit	O
,	O
plasma	O
and	O
whole	B:C0370231
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	O
(	O
hematocrit	O
,	O
plasma	O
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	B:C0014792
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	O
(	O
hematocrit	O
,	O
plasma	O
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	B:C0007580
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	O
(	O
hematocrit	O
,	O
plasma	O
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	B:C0014774
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	O
.	O

Routine	O
laboratory	O
parameters	I:C0022885
and	O
prognostic	O
scores	O
were	O
determined	O
and	O
hemorheological	O
variables	O
(	O
hematocrit	O
,	O
plasma	O
and	O
whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
deformability	O
)	O
were	O
measured	O
on	O
the	O
1st	O
and	O
the	O
2nd	O
day	O
after	O
admission	B:C0184666
.	O

ICU	O
scores	O
predicted	O
35.2	O
-	O
41.3	O
%	O
mortality	O
rate	O
,	O
real	O
mortality	O
in	O
intensive	B:C0021708
care	I:C0021708
unit	I:C0021708
was	O
37.5	O
%	O
,	O
while	O
30	O
-	O
day	O
mortality	O
was	O
46.6	O
%	O
.	O

Whole	B:C1261453
blood	I:C1261453
viscosity	I:C1261453
(	O
Whole	O
blood	I:C1261453
viscosity	I:C1261453
)	O
and	O
red	O
blood	I:C0014774
cell	I:C0014774
(	I:C0014774
RBC	I:C0014774
)	I:C0014774
deformability	I:C0014774
were	O
lower	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
was	O
higher	O
in	O
septic	O
than	O
in	O
nonseptic	O
patients	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Whole	O
blood	I:C1261453
viscosity	I:C1261453
(	O
Whole	B:C1261453
blood	I:C1261453
viscosity	I:C1261453
)	O
and	O
red	O
blood	I:C0014774
cell	I:C0014774
(	I:C0014774
RBC	I:C0014774
)	I:C0014774
deformability	I:C0014774
were	O
lower	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
was	O
higher	O
in	O
septic	O
than	O
in	O
nonseptic	O
patients	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Whole	O
blood	I:C1261453
viscosity	I:C1261453
(	O
Whole	O
blood	I:C1261453
viscosity	I:C1261453
)	O
and	O
red	B:C0014774
blood	I:C0014774
cell	I:C0014774
(	I:C0014774
RBC	I:C0014774
)	I:C0014774
deformability	I:C0014774
were	O
lower	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
was	O
higher	O
in	O
septic	O
than	O
in	O
nonseptic	O
patients	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Whole	O
blood	I:C1261453
viscosity	I:C1261453
(	O
Whole	O
blood	I:C1261453
viscosity	I:C1261453
)	O
and	O
red	O
blood	I:C0014774
cell	I:C0014774
(	I:C0014774
RBC	I:C0014774
)	I:C0014774
deformability	I:C0014774
were	O
lower	O
,	O
red	B:C0014792
blood	I:C0014792
cell	I:C0014792
aggregation	O
was	O
higher	O
in	O
septic	O
than	O
in	O
nonseptic	O
patients	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Whole	O
blood	I:C1261453
viscosity	I:C1261453
(	O
Whole	O
blood	I:C1261453
viscosity	I:C1261453
)	O
and	O
red	O
blood	I:C0014774
cell	I:C0014774
(	I:C0014774
RBC	I:C0014774
)	I:C0014774
deformability	I:C0014774
were	O
lower	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	B:C0007580
was	O
higher	O
in	O
septic	O
than	O
in	O
nonseptic	O
patients	O
(	O
p	O
<	O
0.05	O
)	O
.	O

In	O
septic	B:C0243026
patients	O
calcium	O
was	O
increased	O
,	O
osmolality	O
was	O
decreased	O
,	O
while	O
in	O
nonseptic	O
patients	O

In	O
septic	O
patients	O
calcium	B:C0006675
was	O
increased	O
,	O
osmolality	O
was	O
decreased	O
,	O
while	O
in	O
nonseptic	O
patients	O

In	O
septic	O
patients	O
calcium	O
was	O
increased	O
,	O
osmolality	B:C0086741
was	O
decreased	O
,	O
while	O
in	O
nonseptic	O
patients	O

Whole	B:C1261453
blood	I:C1261453
viscosity	I:C1261453
and	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
were	O
higher	O
in	O
nonsurvivors	O
compared	O
to	O
survivors	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Whole	O
blood	I:C1261453
viscosity	I:C1261453
and	O
red	B:C0014792
blood	I:C0014792
cell	I:C0014792
aggregation	O
were	O
higher	O
in	O
nonsurvivors	O
compared	O
to	O
survivors	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Whole	O
blood	I:C1261453
viscosity	I:C1261453
and	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	B:C0007580
were	O
higher	O
in	O
nonsurvivors	O
compared	O
to	O
survivors	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Whole	O
blood	I:C1261453
viscosity	I:C1261453
and	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
were	O
higher	O
in	O
nonsurvivors	B:C1257890
compared	O
to	O
survivors	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Worsening	O
of	O
red	B:C0014792
blood	I:C0014792
cell	I:C0014792
deformability	O
from	O
day	O
1	O
to	O
day	O
2	O
predicted	O
higher	O
mortality	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Worsening	O
of	O
red	O
blood	I:C0014792
cell	I:C0014792
deformability	B:C0014774
from	O
day	O
1	O
to	O
day	O
2	O
predicted	O
higher	O
mortality	O
(	O
p	O
<	O
0.05	O
)	O
.	O

Calcium	B:C0201925
and	O
osmolality	O
level	I:C0428311
were	O
associated	O
with	O
outcome	O
in	O
sepsis	O
.	O

Calcium	O
and	O
osmolality	B:C0428311
level	I:C0428311
were	O
associated	O
with	O
outcome	O
in	O
sepsis	O
.	O

Calcium	O
and	O
osmolality	O
level	I:C0428311
were	O
associated	O
with	O
outcome	O
in	O
sepsis	B:C0243026
.	O

Whole	B:C0370231
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
change	O
in	O
red	O
blood	I:C0014792
cell	I:C0014792
deformability	O
could	O
predict	O
mortality	O
in	O
nonseptic	O
patients	O
and	O
they	O
may	O
add	O
prognostic	O
information	O
over	O
the	O
ICU	O
scores	O
.	O

Whole	O
blood	I:C0370231
viscosity	O
,	O
red	B:C0014792
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
change	O
in	O
red	O
blood	I:C0014792
cell	I:C0014792
deformability	O
could	O
predict	O
mortality	O
in	O
nonseptic	O
patients	O
and	O
they	O
may	O
add	O
prognostic	O
information	O
over	O
the	O
ICU	O
scores	O
.	O

Whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	B:C0007580
and	O
change	O
in	O
red	O
blood	I:C0014792
cell	I:C0014792
deformability	O
could	O
predict	O
mortality	O
in	O
nonseptic	O
patients	O
and	O
they	O
may	O
add	O
prognostic	O
information	O
over	O
the	O
ICU	O
scores	O
.	O

Whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
change	O
in	O
red	B:C0014792
blood	I:C0014792
cell	I:C0014792
deformability	O
could	O
predict	O
mortality	O
in	O
nonseptic	O
patients	O
and	O
they	O
may	O
add	O
prognostic	O
information	O
over	O
the	O
ICU	O
scores	O
.	O

Whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
change	O
in	O
red	O
blood	I:C0014792
cell	I:C0014792
deformability	B:C0014774
could	O
predict	O
mortality	O
in	O
nonseptic	O
patients	O
and	O
they	O
may	O
add	O
prognostic	O
information	O
over	O
the	O
ICU	O
scores	O
.	O

Whole	O
blood	I:C0370231
viscosity	O
,	O
red	O
blood	I:C0014792
cell	I:C0014792
aggregation	O
and	O
change	O
in	O
red	O
blood	I:C0014792
cell	I:C0014792
deformability	O
could	O
predict	O
mortality	O
in	O
nonseptic	O
patients	O
and	O
they	O
may	O
add	O
prognostic	B:C0033325
information	O
over	O
the	O
ICU	O
scores	O
.	O

Further	O
investigations	B:C0220825
are	O
needed	O
to	O
evaluate	O
the	O
benefit	O
of	O
our	O
findings	O
in	O
clinical	O
practice	O
.	O

Further	O
investigations	O
are	O
needed	O
to	O
evaluate	B:C0220825
the	O
benefit	O
of	O
our	O
findings	O
in	O
clinical	O
practice	O
.	O

Further	O
investigations	O
are	O
needed	O
to	O
evaluate	O
the	O
benefit	O
of	O
our	O
findings	B:C0243095
in	O
clinical	O
practice	O
.	O

